Image
PrEP U™ 2019

HIV-Prevention Education for University Student Health Centers

Meeting Slides

Clinical Practice Guidelines & Recommendations

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations on the International Antiviral Society-USA Panel

Saag MS, et al. JAMA. 2018;320(4):379-396.

Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents.

US Department of Health and Human Services, revised July 16, 2019.

Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living With HIV.

US Department of Health and Human Services, last updated July 10, 2019.

Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement.

USPSTF. JAMA. 2019;321(22):2203-2213.

Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2017 Update. Clinical Practice Guideline

Centers for Disease Control and Prevention, 2017.

Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2017 Update. Clinical Provider’s Supplement

Centers for Disease Control and Prevention, 2017.

Quick Reference Guide: Recommended Laboratory HIV Testing Algorithm for Serum or Plasma Specimens.

Centers for Disease Control and Prevention, 2018.

STD and HIV Screening Recommendations.

Centers for Disease Control and Prevention, 2015.

Clinical Resources

American Academy of HIV Medicine | Supporting the HIV Care Provider and the Profession.

Basic Statistics.

Centers for Disease Control and Prevention, April 2019.

Center of Excellence for Transgender Health.

University of California, San Francisco, School of Medicine, 2018.

Database of Antiretroviral Drug Interactions.

HIV InSite. University of California, San Francisco.

A Guide to Taking a Sexual History.

Centers for Disease Control and Prevention.

HIV Among Youth.

Centers for Disease Control and Prevention, April 2019.

HIV in the United States by Region.

Centers for Disease Control and Prevention, 2018.

HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017.

Centers for Disease Control and Prevention, 2018.

National College Health Assessment II.

American College Health Association, 2015.

PrEP Training Curriculum Modules

Developed by the South African HIV Clinicians Society, this training curriculum is for implementers rolling out PrEP. Modules are available on the PrEP Watch website.

Provider Information Sheet: PrEP During Conception, Pregnancy, and Breastfeeding.

Centers for Disease Control and Prevention.

Sexually Transmitted Diseases.

Centers for Disease Control and Prevention, 2019.

Southeast AETC (AIDS Education & Training Center Program)

Partner Organization

Above the Status Quo

Patient Resources

Centers for Disease Control and Prevention (CDC): HIV Basics.

The CDC is a division within the US Department of Health and Human Services (DHHS), the principal agency for protecting the health of all Americans. This comprehensive site provides extensive links to topics across the HIV-care continuum, including preexposure prophylaxis (PrEP).

HIV Risk Reduction Tool.

Centers for Disease Control and Prevention.

Positively Aware.

Positively Aware, created by TPAN (Test Positive Aware Network), is a source of HIV-treatment news for consumers, as well as an educational tool for HIV caregivers. The site features PrEP resources, including videos for men who have sex with men and transgender people.

Suggested Readings

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.                                                        

Baeten JM, et al. N Engl J Med. 2012;367(5):399-410.

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.

Choopanya K, et al. Lancet. 2013;381(9883):2083-2090.

Implementation of a rapid entry program decreases time to viral suppression among vulnerable persons living with HIV in the southern United States.

Colasanti J, et al. Open Forum Infect Dis. 2018;5(6):ofy104.

Being PrEPared – preexposure prophylaxis and HIV disparities.

Goldstein RH, et al. N Engl J Med. 2018;379(14):1293-1295

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Grant RM, et al. N Engl J Med. 2010;363(27):2587-2599.

HIV Preexposure prophylaxis, by race and ethnicity – United States, 2014-2016.

Huang YA, et al. MMWR Morb Mortal Wkly rep. 2018;67(41):1147-1150.

Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.

Molina JM, et al. Lancet HIV. 2017;4(9):e402-e410.

Challenges in translating PrEP interest into uptake in an observational study of young black MSM.

Rolle CP, et al. J Acquir Immun Defic Syndr. 2017;76(3):250-258.

Willingness to use pre-exposure prophylaxis among black and white men who have sex with men in Atlanta, Georgia.

Rolle CP, et al. Int J STD AIDS. 2017;28(9):849-857.

Relevant Resources

Clinical Updates in Systemic Lupus Erythematosus

Improved Diagnostic and Management Strategies

Advances in Immunosupressive Therapy for Solid Organ Transplantation

Long-Term Management Strategies to Improve Patient Outcomes

Acute Management of Migraine Attacks

Overcoming Pain and Gastrointestinal Distress to Improve Patient Outcomes

Clinical Updates on the Management of Gout

Evidence-Based Strategies for Improved Patient Outcomes

Opioid-Induced Constipation

Proactive Diagnosis and Targeted Management

Chronic Obstructive Pulmonary Disease, Asthma, or Both

Differential Diagnosis and Comprehensive Management Strategies

Improving Outcomes in Chronic Obstructive Pulmonary Disease

Optimizing Maintenance Therapy Across Healthcare Settings

Managing Gout in Primary Care

Evolving Strategies for Diagnosis and Long-Term Management

Clinical Issues in Chronic Pain

Consensus and Controversies for Responsible Opioid Prescribing

Noninsulin Approaches to Managing Type 2 Diabetes

Best Practices in Combination Therapy

Hitting the Target in Type 2 Diabetes

Evolving Approaches to Insulin Based Therapy

Improving Outcomes in Rheumatoid Arthritis

Treating to Target, IL-6-Directed Therapies, and Evolving Management Algorithms

Clearing the Air

Improving Outcomes for Patients with COPD

Clinical Updates in Type 2 Diabetes

New Strategies for Insulin Replacement Therapy

How Low Do You Go?

Clinical Updates in LDL-C Management

Incretin-Based Therapies For Type 2 Diabetes

Improving Comprehensive Patient Care

Improving Outcomes in Non–24-Hour Sleep-Wake Disorder

Identifying Patients and Tailoring Therapy

Comprehensive Management of Chronic Obstructive Pulmonary Disease

Collaborative Approaches to Guideline-Concordant Patient Care

Clinical Updates in the Management of Severe Asthma

New Strategies for Individualizing Long-term Care

Comprehensive Chronic Pain Management

A Focus on Patients With Opioid-Induced Constipation

Clinical Issues in Bipolar Depression

Consensus and Controversies Across the Spectrum of Patient Presentations

Clinical Updates in Rheumatoid Arthritis

Evolving Treatment Algorithms and Expert Perspectives on Biosimilars

Going Deeper on Atopic Dermatitis

Pathophysiology to the Management of Moderate-to-Severe Disease

Caring for Patients with Severe Asthma

Evolving Best Practices to Optimize Outcomes

PrEP for Your Patients’ Needs

The PCPs Role in Preventing HIV

BRIDGE HCV

Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV

Looking Beneath The Surface In Atopic Dermatitis

Targeting Immune Dysregulation and Delivering Comprehensive Care

Can You Spot Axial Spondyloarthritis?

The PCP’s Role in Timely Recognition and Referral

Value-Based HIV Formularies

Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care

Evolving Treatment Paradigms For Rheumatoid Arthritis

Translating Comprehensive Patient Evaluations Into Personalized Therapy

Hepatitis C is Curable

Got it? Treat it!

Clinical Updates in Rheumatoid Arthritis

New Perspectives on Targeting Remission and Individualizing Therapy

Real-World Issues in HIV Prevention & Treatment

The Critical Role of the Community Pharmacist

A Better Look at Rheumatoid Arthritis

Using Imaging to Improve Patient Outcomes

BLOCK HIV/HCV

Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.

Evolving Models of HIV Care

Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box

Clinical Issues in Rheumatoid Arthritis

Discussions and Debates on the Evolving Roles of Targeted Synthetic DMARDs

Advancing the Care of Severe Asthma

Differential Diagnosis, Multidisciplinary Management, and Patient Engagement

Updates in HCV Screening and Treatment

Key Issues Impacting OB/GYN Practice

Pathways to Better Outcomes in Systemic Lupus Erythematosus

Translating Pathophysiology into Targeted Treatments

The Big Picture of IBD

An Interactive Experience Highlighting Recent Clinical Advances

Clinical Issues in Chronic Liver Disease

Hot Topics in HBV, HCV, and NASH

Evolving Models of HIV Care

Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice

Clinical Issues in Rheumatoid Arthritis

Debates & Discussions on the Evolving Role of JAK Inhibitors

Assessing Your Patients for HCV and HIV

Why It Matters in OB/GYN Practice Today

Clearing the Air in Severe Asthma Management

Improving Patient Outcomes Through Shared Clinical Decision Making

HIV as a Chronic Disease

A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities

The Pursuit of Hepatitis C Elimination

How the Pharmacist Can Make a Difference

Clinical Issues in Rheumatoid Arthritis

The Evolving Role of JAK Inhibitors

Trends in Infectious Diseases: Updates on Treatment & Prevention Strategies for HIV and HCV

Understanding the Growing Syndemic — Opioids, HCV, and HIV